Covid-19 Impact on Metagenomics Market, Global Research Reports 2020-2021

2 Global Metagenomics Quarterly Market Size Analysis

• 2.1 Metagenomics Business Impact Assessment - COVID-19
  • 2.1.1 Global Metagenomics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Metagenomics Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Metagenomics Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Metagenomics Headquarters and Area Served
• 3.3 Date of Key Players Enter into Metagenomics Market
• 3.4 Key Players Metagenomics Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Metagenomics Segments, By Type

• 4.1 Introduction
  • 1.4.1 Sequencing
  • 1.4.2 Bioinformatics
• 4.2 By Type, Global Metagenomics Market Size, 2019-2021

5 Impact of Covid-19 on Metagenomics Segments, By Application

• 5.1 Overview
  • 5.5.1 Infectious Disease Diagnosis
  • 5.5.2 Environmental Remediation
  • 5.5.3 Others
• 5.2 By Application, Global Metagenomics Market Size, 2019-2021
  • 5.2.1 By Application, Global Metagenomics Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 SciGenom Labs (India)
  • 7.1.1 SciGenom Labs (India) Business Overview
  • 7.1.2 SciGenom Labs (India) Metagenomics Quarterly Revenue, 2020
  • 7.1.3 SciGenom Labs (India) Metagenomics Product Introduction
  • 7.1.4 SciGenom Labs (India) Response to COVID-19 and Related Developments
• 7.2 ENTEROME Bioscience (France)
  • 7.2.1 ENTEROME Bioscience (France) Business Overview
  • 7.2.2 ENTEROME Bioscience (France) Metagenomics Quarterly Revenue, 2020
  • 7.2.3 ENTEROME Bioscience (France) Metagenomics Product Introduction
  • 7.2.4 ENTEROME Bioscience (France) Response to COVID-19 and Related Developments
• 7.3 Aperiomics (USA)
  • 7.3.1 Aperiomics (USA) Business Overview
  • 7.3.2 Aperiomics (USA) Metagenomics Quarterly Revenue, 2020
  • 7.3.3 Aperiomics (USA) Metagenomics Product Introduction
  • 7.3.4 Aperiomics (USA) Response to COVID-19 and Related Developments
• 7.4 The MITRE Corporation (USA)
  • 7.4.1 The MITRE Corporation (USA) Business Overview
  • 7.4.2 The MITRE Corporation (USA) Metagenomics Quarterly Revenue, 2020
  • 7.4.3 The MITRE Corporation (USA) Metagenomics Product Introduction
  • 7.4.4 The MITRE Corporation (USA) Response to COVID-19 and Related Developments
• 7.5 Quest Diagnostics (USA)
  • 7.5.1 Quest Diagnostics (USA) Business Overview
  • 7.5.2 Quest Diagnostics (USA) Metagenomics Quarterly Revenue, 2020
  • 7.5.3 Quest Diagnostics (USA) Metagenomics Product Introduction
  • 7.5.4 Quest Diagnostics (USA) Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US